M&R Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

M&R Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.25M	Sell	15,442 -84	-0.5%	-$12.2K	0.5%	44
2024 Q2	$2.13M	Sell	15,526 -45	-0.3%	-$6.01K	0.51%	44
2024 Q1	$2.14M	Buy	15,571 +1	+0%	+$137	0.52%	42
2023 Q4	$2.12M	Sell	15,570 -149	-0.9%	-$18.2K	0.53%	39
2023 Q3	$1.92M	Sell	15,719 -49	-0.3%	-$6.23K	0.53%	40
2023 Q2	$2M	Sell	15,768 -453	-3%	-$58.8K	0.52%	40
2023 Q1	$2.09M	Sell	16,221 -930	-5%	-$122K	0.58%	40
2022 Q4	$2.25M	Sell	17,151 -219	-1%	-$28.3K	0.62%	41
2022 Q3	$2.03M	Buy	17,370 +500	+3%	+$62.1K	0.57%	42
2022 Q2	$1.98M	Sell	16,870 -65	-0.4%	-$7.72K	0.52%	46
2022 Q1	$2.21M	Sell	16,935 -100	-0.6%	-$13K	0.47%	46
2021 Q4	$2.6M	Sell	17,035 -105	-0.6%	-$16.3K	0.54%	41
2021 Q3	$2.77M	Sell	17,140 -1,317	-7%	-$222K	0.63%	36
2021 Q2	$3.02M	Sell	18,457 -177	-0.9%	-$27.3K	0.69%	34
2021 Q1	$2.79M	Sell	18,634 -12,510	-40%	-$1.99M	0.69%	34
2020 Q4	$4.72M	Sell	31,144 -740	-2%	-$106K	1.07%	28
2020 Q3	$4.31M	Sell	31,884 -150	-0.5%	-$20.3K	1.07%	26
2020 Q2	$4.37M	Buy	32,034 +4,580	+17%	+$584K	1.17%	25
2020 Q1	$2.96M	Buy	27,454 +650	+2%	+$74.8K	0.88%	27
2019 Q4	$3.23M	Sell	26,804 -300	-1%	-$33.5K	0.73%	38
2019 Q3	$2.69M	Sell	27,104 -609	-2%	-$63.7K	0.63%	43
2019 Q2	$3.07M	Sell	27,713 -460	-2%	-$48.9K	0.69%	40
2019 Q1	$3.07M	Sell	28,173 -701	-2%	-$76.9K	0.7%	40
2018 Q4	$2.83M	Sell	28,874 -3,665	-11%	-$389K	0.74%	37
2018 Q3	$4.01M	Sell	32,539 -30	-0.1%	-$3.53K	0.88%	35
2018 Q2	$3.62M	Sell	32,569 -109	-0.3%	-$11.7K	0.83%	38
2018 Q1	$3.53M	Sell	32,678 -150	-0.5%	-$16.6K	0.82%	37
2017 Q4	$3.55M	Sell	32,828 -2,920	-8%	-$312K	0.82%	35
2017 Q3	$3.98M	Buy	35,748 +75	+0.2%	+$8.02K	0.96%	35
2017 Q2	$3.65M	Sell	35,673 -2,913	-8%	-$287K	0.91%	36
2017 Q1	$3.77M	Buy	38,586 +1,332	+4%	+$128K	0.95%	33
2016 Q4	$3.29M	Sell	37,254 -1,680	-4%	-$153K	0.89%	33
2016 Q3	$3.76M	Buy	38,934 +3,753	+11%	+$357K	1.06%	28
2016 Q2	$3.02M	Buy	35,181 +22,056	+168%	+$1.98M	0.88%	35
2016 Q1	$1.14M	Sell	13,125 -810	-6%	-$72.4K	0.34%	64
2015 Q4	$1.57M	Buy	13,935 +750	+6%	+$81.4K	0.45%	52
2015 Q3	$1.33M	Buy	13,185 +690	+6%	+$82.8K	0.37%	60
2015 Q2	$1.54M	Buy	12,495 +2,250	+22%	+$269K	0.36%	61
2015 Q1	$1.17M	Hold	10,245	–	–	0.28%	71
2014 Q4	$1.04M	Buy	10,245 +420	+4%	+$40.8K	0.25%	75
2014 Q3	$896K	Buy	9,825 +210	+2%	+$18.4K	0.21%	87
2014 Q2	$824K	Sell	9,615 -1,455	-13%	-$115K	0.19%	95
2014 Q1	$872K	Buy	11,070 +330	+3%	+$27.5K	0.21%	89
2013 Q4	$813	Buy	10,740 +720	+7%	+$51.1K	0.21%	88
2013 Q3	$700K	Hold	10,020	–	–	0.2%	88
2013 Q2	$581K	Buy	+10,020	New	+$579K	0.17%	96

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

M&R Capital Management's IBB Position: Q3 2024 in Review

M&R Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 0.54% in Q3 2024, selling an estimated $12.2K and leaving 15,442 shares worth $2.25M. The position accounts for 0.5% of the portfolio, ranked #44.

M&R Capital Management first reported a position in IBB in Q2 2013 and has held it in 46 quarters since. The position peaked at $4.72M in Q4 2020. 895 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

M&R Capital Management held 15,442 shares of iShares Biotechnology ETF worth $2.25M as of Q3 2024.
M&R Capital Management sold 84 iShares Biotechnology ETF shares in Q3 2024, an estimated $12.2K.
iShares Biotechnology ETF made up 0.5% of M&R Capital Management's portfolio in Q3 2024, its #44 holding.
M&R Capital Management first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 46 quarters since.
M&R Capital Management's iShares Biotechnology ETF position peaked at $4.72M in Q4 2020.
895 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.